Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism RNR inhibitors(Ribonucleotide reductase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC13H14N4S2 |
InChIKeyATVSBDLHTRCTLD-UHFFFAOYSA-N |
CAS Registry921768-26-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hematologic Neoplasms | Phase 1 | CN | - | |
Hematologic Neoplasms | Phase 1 | CN | - | |
Non-Small Cell Lung Cancer | Phase 1 | CN | - | |
Non-Small Cell Lung Cancer | Phase 1 | CN | - |